{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:40:35Z","timestamp":1792176035507,"version":"4.4.0"},"reference-count":25,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,5,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Recently, the landscape of single base mutations in diffuse large B-cell lymphoma (DLBCL) was described. Here we report the discovery of a gene fusion between TBL1XR1 and TP63, the only recurrent somatic novel gene fusion identified in our analysis of transcriptome data from 96 DLBCL cases. Based on this cohort and a further 157 DLBCL cases analyzed by FISH, the incidence in de novo germinal center B cell\u2013like (GCB) DLBCL is 5% (6 of 115). The fusion appears exclusive to GCB and was not seen in 138 non-GCB cases examined (P = .008, Fisher exact test) but was present at low incidence in follicular lymphoma (1 of 81). In all 7 cases identified, the 3\u2032 end of the fusion consists of exons 4 and onwards of TP63. The recurrence, subtype enrichment, and the remarkably conserved nature of the TP63 portion of the fusion suggest an important functional role in the lymphomas that harbor this event.<\/jats:p>","DOI":"10.1182\/blood-2012-02-414441","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T06:36:27Z","timestamp":1334212587000},"page":"4949-4952","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":59,"title":["TBL1XR1\/TP63: a novel recurrent gene fusion in B-cell non-Hodgkin lymphoma"],"prefix":"10.1182","volume":"119","author":[{"given":"David W.","family":"Scott","sequence":"first","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Mungall","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Ben-Neriah","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Rogic","sequence":"additional","affiliation":[{"name":"Centre for High-Throughput Biology, University of British Columbia, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan D.","family":"Morin","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham W.","family":"Slack","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC;"},{"name":"Department of Pathology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"King L.","family":"Tan","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fong Chun","family":"Chan","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond S.","family":"Lim","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph M.","family":"Connors","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Marra","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC;"},{"name":"Department of Medical Genetics, University of British Columbia, Vancouver, BC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Mungall","sequence":"additional","affiliation":[{"name":"Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Steidl","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC;"},{"name":"Department of Pathology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy D.","family":"Gascoyne","sequence":"additional","affiliation":[{"name":"Centre for Lymphoid Cancer, British Columbia Cancer Agency, Vancouver, BC;"},{"name":"Department of Pathology, British Columbia Cancer Agency and the University of British Columbia, Vancouver, BC; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"20","key":"2019111809513807200_B1","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM199911113412007","article-title":"Cellular origin of human B-cell lymphomas.","volume":"341","author":"Kuppers","year":"1999","journal-title":"N Engl J Med"},{"key":"2019111809513807200_B2","volume-title":"World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th Ed"},{"issue":"7360","key":"2019111809513807200_B3","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature10351","article-title":"Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma.","volume":"476","author":"Morin","year":"2011","journal-title":"Nature"},{"issue":"9","key":"2019111809513807200_B4","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/ng.892","article-title":"Analysis of the coding genome of diffuse large B-cell lymphoma.","volume":"43","author":"Pasqualucci","year":"2011","journal-title":"Nat Genet"},{"issue":"10","key":"2019111809513807200_B5","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1073\/pnas.1121343109","article-title":"Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing.","volume":"109","author":"Lohr","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7338","key":"2019111809513807200_B6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers.","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"3","key":"2019111809513807200_B7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S1097-2765(00)80275-0","article-title":"p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.","volume":"2","author":"Yang","year":"1998","journal-title":"Mol Cell"},{"issue":"17","key":"2019111809513807200_B8","first-page":"4165","article-title":"Mutational analysis of the p63\/p73L\/p51\/p40\/CUSP\/KET gene in human cancer cell lines using intronic primers.","volume":"59","author":"Hagiwara","year":"1999","journal-title":"Cancer Res"},{"issue":"6046","key":"2019111809513807200_B9","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma.","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"issue":"11","key":"2019111809513807200_B10","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1038\/sj.leu.2402265","article-title":"Mutation of the p51\/p63 gene is associated with blastic crisis in chonic myelogenous leukemia.","volume":"15","author":"Yamaguchi","year":"2001","journal-title":"Leukemia"},{"issue":"5","key":"2019111809513807200_B11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/(SICI)1097-0215(20000601)86:5<684::AID-IJC13>3.0.CO;2-M","article-title":"Frequent gain of the p40\/p51\/p63 gene locus in primary head and neck squamous cell carcinoma.","volume":"86","author":"Yamaguchi","year":"2000","journal-title":"Int J Cancer"},{"issue":"30","key":"2019111809513807200_B12","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1038\/sj.onc.1203656","article-title":"High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)?","volume":"19","author":"Crook","year":"2000","journal-title":"Oncogene"},{"issue":"6","key":"2019111809513807200_B13","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/emboj\/cdg120","article-title":"Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1.","volume":"22","author":"Yoon","year":"2003","journal-title":"EMBO J"},{"issue":"13","key":"2019111809513807200_B14","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1158\/1078-0432.CCR-11-0395","article-title":"Primary central nervous system lymphomas: a validation study of array-based comparative genomic hybridization in formalin-fixed paraffin-embedded tumor specimens.","volume":"17","author":"Braggio","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"11","key":"2019111809513807200_B15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nmeth.1517","article-title":"De novo assembly and analysis of RNA-seq data.","volume":"7","author":"Robertson","year":"2010","journal-title":"Nat Methods"},{"issue":"5","key":"2019111809513807200_B16","doi-asserted-by":"crossref","first-page":"e1001138","DOI":"10.1371\/journal.pcbi.1001138","article-title":"deFuse: an algorithm for gene fusion discovery in tumor RNA-Seq data.","volume":"7","author":"McPherson","year":"2011","journal-title":"PLoS Comput Biol"},{"issue":"2","key":"2019111809513807200_B17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1200\/JCO.2010.30.0368","article-title":"Immunohistochemical methods for predicting cell of origin and survival in patients with diffuse large B-cell lymphoma treated with rituximab.","volume":"29","author":"Meyer","year":"2011","journal-title":"J Clin Oncol"},{"issue":"5","key":"2019111809513807200_B18","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/mp.56.5.275","article-title":"A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples.","volume":"56","author":"Chin","year":"2003","journal-title":"Mol Pathol"},{"issue":"25","key":"2019111809513807200_B19","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1038\/sj.onc.1204427","article-title":"p63alpha and \u0394Np63alpha can induce cell cycle arrest and apoptosis and differentially regulate p53 target genes.","volume":"20","author":"Dohn","year":"2001","journal-title":"Oncogene"},{"issue":"6729","key":"2019111809513807200_B20","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/19539","article-title":"p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development.","volume":"398","author":"Yang","year":"1999","journal-title":"Nature"},{"issue":"6729","key":"2019111809513807200_B21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/19531","article-title":"p63 is a p53 homologue required for limb and epidermal morphogenesis.","volume":"398","author":"Mills","year":"1999","journal-title":"Nature"},{"issue":"3","key":"2019111809513807200_B22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cell.2007.02.045","article-title":"p63 Is essential for the proliferative potential of stem cells in stratified epithelia.","volume":"129","author":"Senoo","year":"2007","journal-title":"Cell"},{"issue":"2","key":"2019111809513807200_B23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2010.04.093","article-title":"Dominant negative (DeltaN) p63alpha induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways.","volume":"396","author":"Mundt","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"2019111809513807200_B24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.molcel.2008.01.020","article-title":"TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR\/SMRT transcriptional repression checkpoints.","volume":"29","author":"Perissi","year":"2008","journal-title":"Mol Cell"},{"issue":"16","key":"2019111809513807200_B25","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1128\/MCB.01600-09","article-title":"The repressing function of the oncoprotein BCL-3 requires CtBP, while its polyubiquitination and degradation involve the E3 ligase TBLR1.","volume":"30","author":"Keutgens","year":"2010","journal-title":"Mol Cell Biol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/21\/4949\/1352077\/zh802112004949.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/119\/21\/4949\/1352077\/zh802112004949.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T15:41:08Z","timestamp":1574091668000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/119\/21\/4949\/29933\/TBL1XR1TP63-a-novel-recurrent-gene-fusion-in-Bcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,24]]},"references-count":25,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2012,5,24]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2012-02-414441","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,24]]}}}